Læknablaðið - 15.06.2000, Side 18

FRÆÐIGREINAR / BARNAGEÐLÆKNINGAR
Helmlldlr
1. Barkley RA. History. In: Barkley RA, ed. Attention Deficit/
Hyperactivity disorder. A handbook for diagnosis and treat-
ment. 2nd ed. New York: Guilford; 1998: 3-40.
2. Chess S. Diagnosis and treatment of the hyperactive child. J
Med 1960; 60:2379-85.
3. American Psychiatric Associat. Diagnostic and statistical
manual of mental disorders. Washington, DC: American
Psychiatric Association; 1987.
4. Barkley RA. Primary symptoms, diagnostic criteria, preval-
ence and gender differences. In: Barkley RA, ed. Attention
Deficit/ Hyperactivity disorder. A handbook for diagnosis and
treatment. 2nd ed. New York: Guilford; 1998:56-96.
5. World Health Organization. The Intemational Classification
of Diseases, lOth revision. Geneva: World Health Organiza-
tion; 1992.
6. American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 4th ed. Washington, DC:
American Psychiatric Association; 1994.
7. Tripp G, Luk SL, Schaughency EA, Singh R. Dsm-iv and icd-
10: a comparison of the correlates of adhd and hyperkinetic
disorder. J Am Acad Child Adolesc Psychiatry 1999; 38: 156-
64.
8. Barkley RA. Defiant children. A clinician's manual for
assessment and parent training. New York: Guilford Press;
1997.
9. DuPaul GJ, Power TJ, Anastopolous AD, Reid R. ADHD
Rating Scale-IV. Checklists, norms and clinical interpretation.
New York: Guilford Press; 1998.
10. Barkley RA, Edelbrock C. Assessing situational variation in
children s problem behaviours: The Home and School Situa-
tions Questionnaires. In: Prinz RJ, ed. Advances in Behavi-
oural Assessment of Children and Families. Greenwich, CT:
JAI Press Inc; 1987:157-67.
11. Achenbach T. Integrative Guide for the 1991 CBCL/4-18,
YSR, & TRF Profiles. Burlington, VT: University of Vermont
Department of Psychiatry; 1991.
12. Magnússon P, Smári J, Grétarsdóttir H, Þrándardóttir H.
Attention-deficit/hyperactivity symptoms in icelandic school
children: assessment with the attention deficit/hyperactivity
rating scale-iv. Scand J Psychol 1999; 40:301-6.
13. Gordon M, Barkley RA. Tests and observational mesures. In:
Barkley RA, ed. Attention Deficit/Hyperactivity disorder. A
handbook for diagnosis and treatment. 2nd ed. New York:
Guilford; 1998: 294-311.
14. Dulcan M. Practice parameters for the assessment and treat-
ment of children, adolescents, and adults with attention-de-
ficit/hyperactivity disorder. American academy of child and
adolescent psychiatry. J Am Acad Child Adolesc Psychiatry
1997; 36: 85S-121S.
15. Landgren M, Kjellman B, Gillberg C. Attention deficit dis-
order with developmental coordination disorders. Arch Dis
Child 1998; 79:207-12.
16. Blackman JA. Attention-deficit/hyperactivity disorder in pre-
schoolers. Does it exist and should we treat it? Pediatr Clin
North Am 1999; 46:1011-25.
17. Palfrey JS, Levine MD, Walker DK, Sullivan M. The emer-
gence of attention deficits in early childhood: A prospective
study. J Dev Behav Pediatr 1985; 6:339-48.
18. Barkley RA. Attention-Deficit/Hyperactivity Disorder. In:
Mash EJ, Barkley RA, eds. Child Psychopathology. New York:
Guilford; 1996: 63-112.
19. Morgan AM. Diagnosis of attention-deficit/hyperactivity dis-
order in the office. Pediatr Clin North Am 1999; 46: 871-84.
20. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of
diagnostic criteria for attention deficit disorders in a German
elementary school sample. J Am Acad Child Adolesc
Psychiatry 1995; 34: 629-38.
21. Gaub M, Carlson CL. Gender differences in ADHD: a meta-
analysis and critical review. J Am Acad Child Adolesc
Psychiatry 1997; 36:1036-45.
22. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A,
Brown J. Comparison of diagnostic criteria for attention-de-
ficit hyperactivity disorder in a county-wide sample. J Am
Acad Child Adolesc Psychiatry 1996; 35: 319-24.
23. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen
PS, Cantwell DP. Attention-deficit hyperactivity disorder and
hyperkinetic disorder. Lancet 1998; 351: 429-33.
24. Szatmari P, Offord DR, Boyle MH. Ontario child health study:
prevalence of attention deficit disorder with hyperactivity. J
Child Psychol Psychiatry 1989; 30:219-30.
25. Barkley RA. Etiologies. In: Barkley RA, ed. Attention De-
ficit/Hyperactivity disorder. A handbook for diagnosis and
treatment. 2nd ed. New York: Guilford; 1998:164-85.
26. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B,
Moore C, et al. Further evidence for family-genetic risk factors
in attention deficit hyperactivity disorder. Patterns of comor-
bidity in probands and relatives psychiatrically and pediatri-
cally referred samples. Arch Gen Psychiatry 1992; 49: 728-38.
27. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines
for pedigree selection in genetic studies of attention deficit
hyperactivity disorder. Genet Epidemiol 2000; 18:1-16.
28. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg
E, Wigal T, et al. Association of the dopamine receptor d4
(drd4) gene with a refined phenotype of attention defícit
hyperactivity disorder (adhd): a family-based approach. Mol
Psychiatry 1998; 3:38-41.
29. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ,
Del'Homme MA, et al. Evidence that the dopamine d4 re-
ceptor is a susceptibility gene in attention deficit hyperactivity
disorder [see comments]. Mol Psychiatry 1998; 3:427-30.
30. Lou HC. Etiology and pathogenesis of attention-deficit hyper-
activity disorder (ADHD): significance of prematurity and
perinatal hypoxic-haemodynamic encephalopathy. Acta
Paediatr 1996; 85:1266-71.
31. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis
AC, Kaysen D, et al. Quantitative morphology of the caudate
nucleus in attention deficit hyperactivity disorder. Am J
Psychiatry 1994; 151:1791-6.
32. Zametkin AJ, Liotta W. The neurobiology of attention-deficit/
hyperactivity disorder. J Clin Psychiatry 1998; 59/Suppl 7: 17-
23.
33. Semrud-Clikeman M. Evidence from imaging on the relation-
ship between brain structure and developmental language dis-
orders. Semin Pediatr Neurol 1997; 4:117-24.
34. Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC,
Hamburger SD, et al. Quantitative morphology of the corpus
callosum in attention deficit hyperactivity disorder [see com-
ments]. Am J Psychiatry 1994; 151:665-9.
35. Hynd GW, Semrud-CIikeman M, Lorys AR, Novey ES, Elio-
pulos D, Lyytinen H. Corpus callosum morphology in atten-
tion deficit-hyperactivity disorder: morphometric analysis of
mri. J Learn Disabil 1991; 24:141-6.
36. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D,
Griffin S. Pharmacotherapy of attention-deficit hyperactivity
disorder across the life cycle. J Am Acad Child Adolesc
Psychiatry 1996; 35:409-32.
37. Cyr M, Brown CS. Current drug therapy recommendations for
the treatment of attention deficit hyperactivity disorder.
Drugs 1998; 56: 215-23.
38. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side
effects of methylphenidate in children with attention deficit
hyperactivity disorder: a systemic, placebo-controlled evalua-
tion. Pediatrics 1990; 86:184-92.
39. Safer D, Allen R, Barr E. Depression of growth in hyperactive
children on stimulant drugs. N Engl J Med 1972; 287:217-20.
40. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz
BA. Stimulant medications precipitate Tourette's syndrome.
JAMA 1982; 247:1729-31.
41. Johnston C, Pelham WE, Hoza J, Sturges J. Psychostimulant
rebound in attention deficit disordered boys. J Am Acad Child
Adolesc Psychiatry 1988; 27: 806-10.
42. Llana ME, Crismon ML. Methylphenidate: increased abuse or
appropriate use? J Am Pharm Assoc (Wash) 1999; 39:526-30.
43. Loney J, Kramer J, Milich RS. The hyperactive child grows up:
predictors of symtoms, delinquency and achievement at
follow-up. In: Gadow KD, Loney J, eds. Psychosocial Aspects
of Drug Treatment for Hyperactivity. Boulder, CO: Westview
Press; 1981: 381-416.
44. Hechtman L. Adolescent outcome of hyperactive children
treated with stimulants in childhood: a review. Psychopharma-
col Bull 1985;21:178-91.
45. Weiss G, Hectman L. Hyperactive children grown up: ADHD
in children, adolescents and adults. 2nd ed. New York: Guil-
ford; 1993.
46. Musten LM, Firestone P, Pisterman S, Bennett S, Mercer J.
Effects of methylphenidate on preschool children with adhd:
cognitive and behavioral functions. J Am Acad Child Adolesc
Psychiatry 1997; 36:1407-15.
47. Daly JM, Wilens T. The use of tricyclic antidepressants in
children and adolescents. Pediatr Clin North Am 1998; 45:
1123-35.
48. Riddle MA, Geller B, Ryan N. Another sudden death in a
child treated with desipramine [see comments]. J Am Acad
Child Adolesc Psychiatry 1993; 32: 792-7.
49. Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT.
Critical review of tricyclic antidepressant use in children and
adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38:
513-6.
418 Læknablaðið 2000/86